Skip to main content

Dr. Charles is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Charles' full profile

Already have an account?

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Gastroenterology, 1996 - 1999
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 1993 - 1996
  • University of the West Indies Faculty of Medical Sciences
    University of the West Indies Faculty of Medical SciencesClass of 1990

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1996 - 2025
  • FL State Medical License
    FL State Medical License 2007 - 2025
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Gulfstream FL-Broward Castle Connolly, 2011-2013
  • Top Doctors:South Florida Castle Connolly, 2012
  • Fellow (FACP) American College of Physicians, 2011
  • Join now to see all

Publications & Presentations

PubMed

Lectures

  • Gastroenterology & Hepatology Symposium (in Conjunction with ACDS 2012 Symposium) 
    Cleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Fort Lauderdale, Florida - 2/17/2012
  • 23rd Annual International Colorectal Disease Symposium & 33rd Annual Turnbull Symposium 
    American Meetings, Inc., Fort Lauderdale, Florida - 2/14/2012

Authored Content

  • Mo1114 FACTORS ASSOCIATED WITH REBLEEDING AFTER ENDOSCOPIC TREATMENT OF GASTROINTESTINAL ARTERIOVENOUS MALFORMATIONS. A RETROSPECTIVE MULTI-CENTER STUDYMay 2018
  • Mo1114 FACTORS ASSOCIATED WITH REBLEEDING AFTER ENDOSCOPIC TREATMENT OF GASTROINTESTINAL ARTERIOVENOUS MALFORMATIONS. A RETROSPECTIVE MULTI-CENTER STUDYMay 2018

Press Mentions

  • Unheard of: Immunotherapy Drug That in Trial Cured This Cancer Every Time
    Unheard of: Immunotherapy Drug That in Trial Cured This Cancer Every TimeJune 16th, 2022
  • Experimental Immunotherapy Drug Has 100% Cure Rate for Rectal Cancer
    Experimental Immunotherapy Drug Has 100% Cure Rate for Rectal CancerJune 16th, 2022
  • Colon Cancer Hits Hardest in Communities of Color
    Colon Cancer Hits Hardest in Communities of ColorSeptember 9th, 2020

Professional Memberships

Hospital Affiliations